Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis
NCT00666159 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 226
Last updated 2014-09-18
Summary
Comparison of Protopic Ointment to Elidel Cream to assess the safety and efficacy in pediatric patients with Atopic Dermatitis
Conditions
- Dermatitis, Atopic
Interventions
- DRUG
-
tacrolimus ointment
topical
- DRUG
-
pimecrolimus cream
topical
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use central contact · Astellas Pharma US, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2003-05-31
- Completion
- 2003-05-31
Countries
- United States
Study Locations
More Related Trials
-
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
NCT01177566 ·Status: COMPLETED ·Phase: PHASE4
-
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
NCT01202149 ·Status: COMPLETED ·Phase: PHASE4
-
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT00475605 ·Status: TERMINATED
-
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
NCT00535691 ·Status: COMPLETED ·Phase: PHASE2
-
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
NCT00560326 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
NCT01745159 ·Status: COMPLETED ·Phase: PHASE4
-
Combination Therapy for Atopic Dermatitis
NCT00119158 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
NCT00106496 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects
NCT00139581 ·Status: COMPLETED ·Phase: PHASE4
-
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
NCT00148746 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
NCT00691262 ·Status: COMPLETED ·Phase: PHASE3
-
10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus
NCT00568997 ·Status: ACTIVE_NOT_RECRUITING
-
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
NCT02601703 ·Status: COMPLETED ·Phase: PHASE3
-
Protopic Ointment in Adult Atopic Eczema of the Face
NCT00690105 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis
NCT00130364 ·Status: COMPLETED ·Phase: PHASE4
-
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
NCT03107611 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old
NCT00510003 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
NCT00691145 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
NCT04900948 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Safety of Protopic in Atopic Eczema
NCT00560378 ·Status: COMPLETED ·Phase: PHASE3
-
Short Term Growth in Children With Atopic Dermatitis
NCT00236106 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
NCT00480610 ·Status: COMPLETED ·Phase: PHASE3
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis
NCT05186805 ·Status: COMPLETED ·Phase: PHASE2